---
title: "C.3.A:A.4 Worked examples \\[I]"
description: "Generated reference page for heading:c-3-a-a-4-worked-examples-i:34166."
---

# C.3.A:A.4 Worked examples \[I]
> Preface node `heading:c-3-a-a-4-worked-examples-i:34166`

## Content

**(1) Healthcare — “Adult” dosage rule across jurisdictions**

*Reg source.* Jurisdiction Y defines `AdultPerson@RegY` (AT around K2, F4) with **age at least 18**; your hospital Context uses `AdultPatient` (**age at least 21**).
*Claim.* “For all `x ∈ AdultPatient`: dosage ≤ D/kg for drug M.”
*Adoption.*

* **KindBridge.** Map `AdultPerson@RegY → AdultPatient`; **`CL^k = 1`**; **loss note:** boundary mismatch (18↔21).
* **Scope.** `{jurisdiction=Y, formulary=M, time selector (Γ_time)=from 2026‑01‑01}`.
* **Guard.** `Guard_RegAdopt` passes; **R** penalized by `Ψ(1)`. Policy narrows Scope to mapped cohort (age≥21) for in‑house use.
* **Change.** If Y changes adult to ≥19 (new edition), run `Guard_RegChange`: version the kind, refresh the bridge, re‑assess `CL^k`, update guards.

**(2) Privacy — GDPR↔CCPA PII across Contexts**

*Reg kinds.* `PersonalData@GDPR`, `PersonalInformation@CCPA`.
*Internal kind.* `PersonalData@Product` with masks per data store.
*Policy claim.* “No sharing of `SensitiveAttribute` outside processors.”
*Adoption.*

* **KindBridges.** `SensitiveAttribute@GDPR → SensitiveAttribute@Product` (**`CL^k=2`**); `SensitivePersonalInformation@CCPA → SensitiveAttribute@Product` (**`CL^k=1`**, loss: biometric nuance).
* **Scope.** Two policies with **SpanUnion** over `{jurisdiction=EU}` and `{jurisdiction=CA}`, each with its own **Γ\_time** windows and evidence freshness.
* **Guards.** For CA, apply stronger **R** penalty (`Ψ(1)`), and narrow to the mapped subset (exclude ambiguous fields).
* **Do not.** Do not rename GDPR terms to local labels **without a KindBridge**.

**(3) Export control — US EAR “600‑series” classification**

*Reg kind.* `EAR600SeriesItem@US` (AT≈K2, F3→F4 as predicates are formalized).
*Local kind.* `Product@Company`.
*Work scope.* `{destination=countries, end_use, time selector (Γ_time)=shipment date}` for the shipping capability.
*Adoption.*

* **KindBridge.** Map `EAR600SeriesItem@US → Product@Company`; `CL^k=2` (loss: component kit edge cases); loss notes recorded.
* **Capability guard (Method–Work).**

  * `U.WorkScope(Ship)` covers `JobSlice` (destination, end use, time).
  * `MemberOf(product, EAR600_mapped, JobSlice)` defined (classification present).
  * Apply `Ψ(2)` to **R** (classification uncertainty) and, if reusing US scope text, `Φ(CL_scope)` too.
* **Outcome.** Shipment admitted only for allowed destinations; higher **R** may require manual review.

**(4) Finance — IFRS vs US GAAP “Lease”**

*Reg kinds.* `Lease@IFRS`, `Lease@USGAAP`.
*Local kind.* `LeaseStandard@Corp` used in policy “recognize lease liabilities.”
*Adoption.*
* **KindBridge.** `Lease@IFRS → LeaseStandard@Corp` (**`CL^k=2`**; loss: short‑term exceptions differ).
* **Scope.** `{jurisdiction=IFRS, Γ_time=financial period, ledger=v7}`.
* **Evidence.** LA plans cover subkinds (operating vs finance) per your classification; the kind‑bridge congruence level (CL^k) drives extra testing near boundary cases.
